Eurofins Genomics SARS-CoV-2 NGS Service, ARTIC Oligo Mix

Eurofins Genomics has launched a SARS-CoV-2 next-generation sequencing service providing full-length viral genome sequences, and will shortly launch its ARTIC NGS oligo mix. The service and oligo mix are based on a protocol by the ARTIC consortium, which is used for SARS-CoV-2 sequencing worldwide. The ARTIC approach utilizes an oligo pool for multiplexed PCR amplification of the complete viral genome. Eurofins Genomics said that it optimized the formulation of the oligo pool for highest performance and uniformity of coverage for the full-length viral genome. Eurofins is offering part of its sequencing capacity for free to public healthcare authorities who do not have emergency budgets available to detect the VUI2020-12/01 strain reported to be currently fast-spreading in the UK.